Skip to main content
Journal cover image

Dual Recombinase Technology Defines a Therapeutic Window for ATM Inhibitors to Selectively Radiosensitize Tumors

Publication ,  Conference
Moding, E; Lee, C; Castle, KD; Oh, P; Kirsch, DG
Published in: International Journal of Radiation Oncology*Biology*Physics
September 2014

Duke Scholars

Published In

International Journal of Radiation Oncology*Biology*Physics

DOI

ISSN

0360-3016

Publication Date

September 2014

Volume

90

Issue

1

Start / End Page

S35 / S35

Publisher

Elsevier BV

Related Subject Headings

  • Oncology & Carcinogenesis
  • 5105 Medical and biological physics
  • 3407 Theoretical and computational chemistry
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
  • 0299 Other Physical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Moding, E., Lee, C., Castle, K. D., Oh, P., & Kirsch, D. G. (2014). Dual Recombinase Technology Defines a Therapeutic Window for ATM Inhibitors to Selectively Radiosensitize Tumors. In International Journal of Radiation Oncology*Biology*Physics (Vol. 90, pp. S35–S35). Elsevier BV. https://doi.org/10.1016/j.ijrobp.2014.05.147
Moding, E., C. Lee, K. D. Castle, P. Oh, and D. G. Kirsch. “Dual Recombinase Technology Defines a Therapeutic Window for ATM Inhibitors to Selectively Radiosensitize Tumors.” In International Journal of Radiation Oncology*Biology*Physics, 90:S35–S35. Elsevier BV, 2014. https://doi.org/10.1016/j.ijrobp.2014.05.147.
Moding E, Lee C, Castle KD, Oh P, Kirsch DG. Dual Recombinase Technology Defines a Therapeutic Window for ATM Inhibitors to Selectively Radiosensitize Tumors. In: International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2014. p. S35–S35.
Moding, E., et al. “Dual Recombinase Technology Defines a Therapeutic Window for ATM Inhibitors to Selectively Radiosensitize Tumors.” International Journal of Radiation Oncology*Biology*Physics, vol. 90, no. 1, Elsevier BV, 2014, pp. S35–S35. Crossref, doi:10.1016/j.ijrobp.2014.05.147.
Moding E, Lee C, Castle KD, Oh P, Kirsch DG. Dual Recombinase Technology Defines a Therapeutic Window for ATM Inhibitors to Selectively Radiosensitize Tumors. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2014. p. S35–S35.
Journal cover image

Published In

International Journal of Radiation Oncology*Biology*Physics

DOI

ISSN

0360-3016

Publication Date

September 2014

Volume

90

Issue

1

Start / End Page

S35 / S35

Publisher

Elsevier BV

Related Subject Headings

  • Oncology & Carcinogenesis
  • 5105 Medical and biological physics
  • 3407 Theoretical and computational chemistry
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
  • 0299 Other Physical Sciences